Home
Live Updates
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2024 Earnings Call Transcript : comparemela.com
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2024 Earnings Call Transcript
Amneal Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.29824 EPS, expectations were $0.09. Amneal Pharmaceuticals, Inc.
Related Keywords
South Africa ,
Mexico ,
China ,
Canada ,
India ,
Philippines ,
California ,
United States ,
New Jersey ,
State Of California ,
Saudi Arabia ,
America ,
American ,
Americans ,
David Amsellem ,
Chintu Patel ,
Chirag Patel ,
Balaji Prasad ,
Jason Daly ,
Piper Sandler ,
Tony Dimeo ,
Chris Schott ,
Tasos Konidaris ,
Joe Renda ,
Randy Boyer ,
Leszek Sulewski ,
Goldman Sachs ,
Anthony ,
Amneal Pharmaceuticals ,
Amneal Pharmaceuticals First Quarter ,
Amneal Pharmaceuticals Inc ,
Barclays ,
Parkinson Foundation ,
Call Transcript May ,
Investor Relations ,
Cautionary Statements ,
Forward Looking Statements ,
Chief Legal ,
Trucking Stocks ,
Profitable Stocks ,
Nathan Rich ,
comparemela.com © 2020. All Rights Reserved.